FEATURED ARTICLES

• Building Trust In AI For Computerized System Validation

  Using AI for CSV might feel like the students are grading their own papers. One consultant explains why it's not the same, namely, there are no subjective judgment calls.

• When To Trust And When To Verify AI-Enabled Validation Systems
• A Late-Stage QTPP, CQA, And CPP Mapping Guide
• Controls For Retrieval-Augmented Generation In GxP
• Aseptic Bag Filling: Meeting Annex 1 Without Compromise, Aseptic Filling Technologies That Ensure GMP Compliance And Product Success

WHITE PAPERS & CASE STUDIES

• Digital CMC Maturity: Rethinking QTTP And Control Strategy

  Digital CMC maturity depends on structured, science- and risk-based knowledge. Learn how connecting development, validation, regulatory, and lifecycle information can accelerate timelines.

• Robust Database Characterizes And Optimizes Product Development

  Integrating material characterization data with process parameters accelerates drug development, reduces empirical testing, and strengthens regulatory compliance.

• Determining The True Cost Of Single-Use Fluid Management

  Looking beyond unit price reveals how reliability, leak prevention, and shelf life affect bioprocessing costs. Make purchasing decisions that support resilient and predictable operations.

• Improving AAV Manufacturing: Advancements In Full Capsid Enrichment

  As AAV manufacturing matures, integrated optimization of capture, buffer chemistry, load conditioning, and AEX polishing enables scalable full capsid enrichment, improving product quality and manufacturability.

• Systemic Modularity: A Roadmap To Flexible, Efficient Biopharmaceutical Manufacturing

  Modernizing biomanufacturing requires shifting from rigid, custom setups toward modular automation, data-rich sensors, and plug-and-produce operations. 

• GLP-1 Peptides Around The World

  Explore how evolving regulations, supply constraints, and reimbursement models shape GLP-1 drug development across the U.S., Europe, and Asia.